Puretech Health PLC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Citigroup Inc. and its subsidiaries have reported beneficial ownership of 14,636,273 ordinary shares, representing 6.0% of PureTech Health plc.
NASDAQ
Tang Capital Management, LLC and affiliated entities have reported beneficial ownership of 5.19% of PureTech Health plc's ordinary shares.
NASDAQ
Citigroup and its affiliates have disclosed a 5.5% beneficial ownership stake in Puretech Health Plc, holding over 13.2 million ordinary shares.
NASDAQ
Citigroup Global Markets Limited and affiliated entities have filed an amended Schedule 13G, reporting a collective beneficial ownership of 4.5% of Puretech Health Plc's Ordinary Shares as of December 31, 2024.